CD4 and respiratory system disorder: Previously, the CD4 TH2 phenotype has been associated with vaccine-associated enhanced respiratory disease (VAERD) in patients vaccinated against rubella (47), respiratory syncytial virus (48), and in preclinical studies of potential SARS and MERS vaccines (49, 50).